05.04.26 -- Why Europe's Scientific Edge Still Struggles To Attract Global Capital

Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.

Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.

Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

Once used primarily by large sponsors and concentrated in areas like monitoring, biometrics, and safety, functional service providers (FSPs) have evolved alongside the growing complexity and cost of clinical research.

See how a chemically diverse, lead‑like compound library uses advanced filtering to enhance hit discovery, accelerate hit‑to‑lead development, and strengthen early‑stage small‑molecule drug discovery.